These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30485339)

  • 1. Novel high-throughput myofibroblast assays identify agonists with therapeutic potential in pulmonary fibrosis that act via EP2 and EP4 receptors.
    Sieber P; Schäfer A; Lieberherr R; Le Goff F; Stritt M; Welford RWD; Gatfield J; Peter O; Nayler O; Lüthi U
    PLoS One; 2018; 13(11):e0207872. PubMed ID: 30485339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Prostaglandin FP and EP2 Receptors Differently Modulates Myofibroblast Transition in a Model of Adult Primary Human Trabecular Meshwork Cells.
    Kalouche G; Beguier F; Bakria M; Melik-Parsadaniantz S; Leriche C; Debeir T; Rostène W; Baudouin C; Vigé X
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1816-25. PubMed ID: 27082296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of prostaglandin E(2) on the migration of nasal fibroblasts.
    Shin JM; Park IH; Moon YM; Hong SM; Cho JS; Um JY; Lee HM
    Am J Rhinol Allergy; 2014; 28(3):e120-4. PubMed ID: 24980222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FLECS technology for high-throughput screening of hypercontractile cellular phenotypes in fibrosis: A function-first approach to anti-fibrotic drug discovery.
    Wang Y; Cortes E; Huang R; Wan J; Zhao J; Hinz B; Damoiseaux R; Pushkarsky I
    SLAS Discov; 2024 Apr; 29(3):100138. PubMed ID: 38158044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT2B receptor antagonists attenuate myofibroblast differentiation and subsequent fibrotic responses in vitro and in vivo.
    Löfdahl A; Rydell-Törmänen K; Müller C; Martina Holst C; Thiman L; Ekström G; Wenglén C; Larsson-Callerfelt AK; Westergren-Thorsson G
    Physiol Rep; 2016 Aug; 4(15):. PubMed ID: 27482070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emodin alleviates bleomycin-induced pulmonary fibrosis in rats.
    Guan R; Zhao X; Wang X; Song N; Guo Y; Yan X; Jiang L; Cheng W; Shen L
    Toxicol Lett; 2016 Nov; 262():161-172. PubMed ID: 27717887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-30d/JAG1 axis modulates pulmonary fibrosis through Notch signaling pathway.
    Zhao S; Xiao X; Sun S; Li D; Wang W; Fu Y; Fan F
    Pathol Res Pract; 2018 Sep; 214(9):1315-1323. PubMed ID: 30029934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostanoid receptors EP2, EP4, and FP are regulated by estradiol in bovine oviductal smooth muscle.
    Huang N; Liu B; Dong Z; Mao W; Zhang N; Li C; Cao J
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):170-5. PubMed ID: 26319698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
    Usuki J; Matsuda K; Azuma A; Kudoh S; Gemma A
    J Nippon Med Sch; 2012; 79(1):46-59. PubMed ID: 22398790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of the Transcriptome by Prostaglandin E2 during Myofibroblast Dedifferentiation.
    Wettlaufer SH; Scott JP; McEachin RC; Peters-Golden M; Huang SK
    Am J Respir Cell Mol Biol; 2016 Jan; 54(1):114-27. PubMed ID: 26098591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation.
    Kolodsick JE; Peters-Golden M; Larios J; Toews GB; Thannickal VJ; Moore BB
    Am J Respir Cell Mol Biol; 2003 Nov; 29(5):537-44. PubMed ID: 12738687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic inhibition of lactate production prevents myofibroblast differentiation.
    Kottmann RM; Trawick E; Judge JL; Wahl LA; Epa AP; Owens KM; Thatcher TH; Phipps RP; Sime PJ
    Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(11):L1305-12. PubMed ID: 26408551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor-1 attenuates TGF-β1-induced lung fibrosis.
    Shimbori C; Bellaye PS; Xia J; Gauldie J; Ask K; Ramos C; Becerril C; Pardo A; Selman M; Kolb M
    J Pathol; 2016 Oct; 240(2):197-210. PubMed ID: 27425145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation.
    Kuriyama S; Kashiwagi H; Yuhki K; Kojima F; Yamada T; Fujino T; Hara A; Takayama K; Maruyama T; Yoshida A; Narumiya S; Ushikubi F
    Thromb Haemost; 2010 Oct; 104(4):796-803. PubMed ID: 20664890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
    Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
    Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
    Iwanaga K; Okada M; Murata T; Hori M; Ozaki H
    J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
    Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
    J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
    Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.